![Acumen Pharmaceuticals Inc](/common/images/company/N_ABOS.png)
Acumen Pharmaceuticals Inc (ABOS)
NASDAQ
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Total Assets | 211.68M | 203.26M | 196.59M | 187.86M | 177.41M | 286.37M | 310.13M | 300.97M |
Total Current Assets | 191.05M | 202.56M | 180.33M | 144.03M | 149.54M | 218.6M | 246.62M | 255.83M |
Cash and Equivalents | 111.07M | 157.54M | 130.1M | 78M | 77.25M | 94.92M | 66.89M | 46.93M |
Total Non-Current Assets | 20.63M | 704k | 16.42M | 43.83M | 27.87M | 67.77M | 63.51M | 45.14M |
Total Liabilities | 5.16M | 6.61M | 7.81M | 8.78M | 8.53M | 6.1M | 43.15M | 38.93M |
Total Current Liabilities | 5.13M | 6.61M | 7.81M | 8.78M | 8.53M | 6.1M | 12.97M | 8.47M |
Total Non-Current Liabilities | 25k | 0 | 0 | 0 | 0 | 0 | 60.08M | 60.67M |
Common Equity | 4k | 4k | 4k | 4k | 4k | 6k | 6k | 6k |
Retained Earnings | -146.85M | -157.56M | -170.43M | -181.73M | -193.34M | -206.3M | -222.8M | -237.67M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 7.32M | 44.43M | 230.33M | 196.59M | 310.13M |
Total Current Assets | 7.18M | 44.43M | 198.66M | 180.33M | 246.62M |
Cash and Equivalents | 6.55M | 43.78M | 122.16M | 130.1M | 66.89M |
Total Non-Current Assets | -11.42M | -18.59M | 225.18M | 188.78M | 266.97M |
Total Liabilities | 1.34M | 6.37M | 5.15M | 7.81M | 43.15M |
Total Current Liabilities | 1.34M | 6.37M | 5.15M | 7.81M | 12.97M |
Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 60.08M |
Total Equity | -11.42M | -18.59M | 225.18M | 188.78M | 266.97M |
Common Equity | 0 | 0 | 4k | 4k | 6k |
Retained Earnings | -19.64M | -26.97M | -127.57M | -170.43M | -222.8M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.